Journals / Uludağ Üniversitesi Tıp Fakültesi Dergisi / 2021 / Cilt: 47 - Sayı: 1

Is Pathological Fracture Predictable in Patients with Postmenopausal Osteoporosis?

Postmenopozal Osteoporozlu Hastalarda Patolojik Kırık Oluşumu Öngörülebilir mi?

Pages
49–53
Publication Date
2021-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although the results suggest that it is difficult to accurately predict fracture formation, they suggest that studies that will screen a larger patient population with more data are needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Osteoporosis (OP) is a metabolic bone disease characterized by a decrease in bone mass and an increase in bone fragility.
📊
Key Findings & Data:The aim of this study is to determine whether fracture risk can be predicted in patients with PMO. 124 patients diagnosed with PMO who admitted to the Physical Medicine and Rehabilitation outpatient department were included in the study.
💡
Conclusion & Impact:Although the results suggest that it is difficult to accurately predict fracture formation, they suggest that studies that will screen a larger patient population with more data are needed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Postmenopozal osteoporoz · Kemik mineral yoğunluğu · Patolojik kırık

Abstract

Osteoporosis (OP) is a metabolic bone disease characterized by a decrease in bone mass and an increase in bone fragility. The most important cause of morbidity and mortality of OP is osteoporotic fracture formation. Although there are many studies carried out to define fracture risk factors in postmenopausal osteoporosis (PMO), there is still controversy in these studies about which risk factor is actually effective in fracture formation. The aim of this study is to determine whether fracture risk can be predicted in patients with PMO. 124 patients diagnosed with PMO who admitted to the Physical Medicine and Rehabilitation outpatient department were included in the study. The presence of fractures and risk factors that may cause fractures in these patients were screened retrospectively. The patients were divided into two groups according to the presence of fractures, as patients with PMO with and without fractures and compared. While osteoporotic fractures were found in 50 of the patients with PMO (40,3%), no fractures were found in 74 patients (59,7%). As a result of the comparison between the two groups, a statistically significant relationship was found between advanced age and fracture formation. There was no significant relationship between body mass index (BMI), age at menopause, vitamin 25 (OH) D levels, bone mineral density (BMD) measurement T scores evaluated by dual-energy X-ray absorptiometry (DEXA) and fracture formation. Although the results suggest that it is difficult to accurately predict fracture formation, they suggest that studies that will screen a larger patient population with more data are needed.

Özet

Osteoporoz (OP), kemik kütlesinde azalma ve kemik kırılganlığında artış ile karakterize metabolik bir kemik hastalığıdır. OP’nin en önemli morbidite ve mortalite nedeni osteoporotik kırık oluşumudur. Postmenopozal osteoporozda (PMO) kırık risk faktörlerini tanımlamak amacıyla yapılan birçok çalışma bulunmasına rağmen, bu çalışmalarda kırık oluşumunda gerçekte hangi risk faktörünün ne kadar etkili olduğu konusundaki bilgiler halen çelişkilidir. Bu çalışmada amaç, PMO’lu hastalarda kırık riskinin öngörülüp öngörülemeyeceğini belirlemektir. Fiziksel Tıp ve Rehabilitasyon Polikliniği’ne başvuran PMO tanılı 124 hasta çalışmaya dahil edildi. Bu hastaların kırık varlığı ve kırığa neden olabilecek risk faktörleri geriye yönelik olarak tarandı. Hastalar kırık varlığına göre, kırığı olan ve olmayan PMO’lu hastalar olarak iki gruba ayrılarak karşılaştırıldı. PMO’lu hastaların 50’sinde (%40,3) osteoporotik kırık saptanırken, 74 hastada (%59,7) kırık saptanmadı. İki grup arasında yapılan karşılaştırma sonucunda ileri yaş ile kırık oluşumu arasında istatistiksel olarak anlamlı ilişki saptandı. Vücut kitle indeksi (VKİ), menopoz yaşı, 25(OH) D vitamini düzeyleri, dual-enerji X-ışını absorbsiyometri (DEXA) ile değerlendirilen kemik mineral yoğunluğu (KMY) ölçümü T skorları ile kırık oluşumu arasında anlamlı ilişki saptanmadı. Sonuçlar kırık oluşumunun tam olarak öngörülmesinin zor olduğunu düşündürmekle birlikte, daha fazla sayıda veri ile yapılacak daha geniş hasta popülasyonunun tarandığı çalışmalara ihtiyaç olduğunu düşündürmektedir.

🔖

Cite This Article

ERTEM, U., İRDESEL, J. (2021). Is Pathological Fracture Predictable in Patients with Postmenopausal Osteoporosis?. Uludağ Üniversitesi Tıp Fakültesi Dergisi, Cilt: 47 - Sayı: 1, 49–53. https://ajindex.com/articles/134674

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. TFTR Derneği Osteoporoz Çalışma grubu. Postmenopozal Osteoporoz Tanı ve Tedavisinde Kanıta dayalı öneriler. TFTR Derneği Osteoporoz Çalışma grubu uzlaşı raporu 2017
  2. Odabaşı E, Turan M, Bilgiç S, Kutlu M. Osteoporotik Kırıkların Doğum Sayısı ve Fertil Dönem Süresi ile İlişkisi. TAF Prev Med Bull 2009
  3. 8(1):1-4. 3.Altunbayrak O. Pasif Sigara İçimi Postmenopozal Osteoporoz İçin Bir Risk Faktörü müdür ? (Uzmanlık Tezi). İstanbul: İstanbul Eğitim ve Araştırma Hastanesi
  4. Bozbey I, Yalçın AP. Postmenopozal Osteoporoz Tedavisinde Stronsiyum Ranelat. Turk J Rheumatol 2009
  5. Kanis JA, Borgstrom F, Laet CD, et al. Assessment of fracture risk. Osteoporos Int. 2005
  6. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991
  7. 114(11):919-23. 7.Coughlan T, Dockery F. Osteoporosis and fracture risk in older people. Clin Med (Lond). 2014 Apr
  8. 14(2):187-91. 8.Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ. 2009 Nov 19
  9. b4229. 9.Ogura-Tomamatsu H, Asano K, Tomamatsu K, et al. Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease. COPD. 2012 Aug
  10. 9(4):332-7. 10.Lai EL, Huang WN, Chen HH, et al. Ten-year fracture risk by FRAX and osteoporotic fractures in patients with systemic autoimmune diseases. Lupus. 2019 Jul
  11. 28(8):945-53. 11.Crandall CJ, Larson J, LaCroix A, et al. Predicting Fracture Risk in Younger Postmenopausal Women: Comparison of the Garvan and FRAX Risk Calculators in the Women's Health Initiative Study. J Gen Intern Med. 2019 Feb
  12. 34(2):235-42. 12.Lindsay R, Pack S, Li Z. Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis. Osteoporos Int. 2005 Mar
  13. 16(3):306-12. 13.Ma X, Xia H, Wang J, et al. Re-fracture and correlated risk factors in patients with osteoporotic vertebral fractures. J Bone Miner Metab. 2019 Jul
  14. 37(4):722-8. 14.Yusuf AA, Hu Y, Chandler D, Crittenden DB, Barron RL. Predictors of imminent risk of fracture in Medicare-enrolled men and women. Arch Osteoporos. 2020 Aug 3
  15. 15(1):120. 15.Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019 Jan
  16. 30(1):3-44. 16.Çolak Y, Afzal